1. Home
  2. AVIR vs PANL Comparison

AVIR vs PANL Comparison

Compare AVIR & PANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVIR
  • PANL
  • Stock Information
  • Founded
  • AVIR 2012
  • PANL 1996
  • Country
  • AVIR United States
  • PANL United States
  • Employees
  • AVIR N/A
  • PANL N/A
  • Industry
  • AVIR Medicinal Chemicals and Botanical Products
  • PANL Marine Transportation
  • Sector
  • AVIR Health Care
  • PANL Consumer Discretionary
  • Exchange
  • AVIR Nasdaq
  • PANL Nasdaq
  • Market Cap
  • AVIR 290.4M
  • PANL 328.2M
  • IPO Year
  • AVIR 2020
  • PANL N/A
  • Fundamental
  • Price
  • AVIR $3.37
  • PANL $5.35
  • Analyst Decision
  • AVIR Hold
  • PANL Strong Buy
  • Analyst Count
  • AVIR 1
  • PANL 1
  • Target Price
  • AVIR $6.00
  • PANL $9.00
  • AVG Volume (30 Days)
  • AVIR 306.9K
  • PANL 204.4K
  • Earning Date
  • AVIR 11-06-2025
  • PANL 08-07-2025
  • Dividend Yield
  • AVIR N/A
  • PANL 3.74%
  • EPS Growth
  • AVIR N/A
  • PANL N/A
  • EPS
  • AVIR N/A
  • PANL 0.16
  • Revenue
  • AVIR N/A
  • PANL $579,781,169.00
  • Revenue This Year
  • AVIR N/A
  • PANL $13.00
  • Revenue Next Year
  • AVIR N/A
  • PANL N/A
  • P/E Ratio
  • AVIR N/A
  • PANL $33.21
  • Revenue Growth
  • AVIR N/A
  • PANL 15.10
  • 52 Week Low
  • AVIR $2.46
  • PANL $3.93
  • 52 Week High
  • AVIR $4.15
  • PANL $7.50
  • Technical
  • Relative Strength Index (RSI)
  • AVIR 42.27
  • PANL 59.08
  • Support Level
  • AVIR $3.35
  • PANL $5.11
  • Resistance Level
  • AVIR $3.86
  • PANL $5.48
  • Average True Range (ATR)
  • AVIR 0.13
  • PANL 0.14
  • MACD
  • AVIR -0.02
  • PANL 0.01
  • Stochastic Oscillator
  • AVIR 14.78
  • PANL 74.76

About AVIR Atea Pharmaceuticals Inc.

Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).

About PANL Pangaea Logistics Solutions Ltd.

Pangaea Logistics Solutions Ltd and its subsidiaries provide seaborne drybulk logistics and transportation services. It transports various drybulk cargoes including grains, coal, iron, ore, pig, iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The company provides ocean transportation services to clients utilizing an ocean-going fleet of motor vessels in the Handymax, Supramax, Ultramax, Panamax, and Post-Panamax segments. Its services include cargo loading, cargo discharge, vessel chartering, voyage planning, and technical vessel management. The company derives all of its revenues from contracts of affreightment, voyage charters and time charters. Geographically, it derives key revenue from the United States, followed by Canada, Germany, and others.

Share on Social Networks: